Article Information
History
- May 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Macarius M. Donneyong1,2,*,
- Yuxi Zhu3,
- Teng-Jen Chang1,
- Pengyue Zhang4,
- Yiting Li2,
- Katherine M. Hunold5,
- ChienWei Chiang6,
- Kathleen Unroe7,
- Jeffrey M. Caterino5 and
- Lang Li6
- 1Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH
- 2Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH
- 3Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH
- 4Department of Biostatistics, School of Medicine, Indiana University, Indianapolis, IN
- 5Department of Emergency Medicine, College of Medicine, The Ohio State University, Columbus, OH
- 6Division of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH
- 7Indiana University School of Medicine, Indianapolis, IN
- ↵*Corresponding author
: Macarius M. Donneyong, PhD, MPH, Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, 496 W. 12th Ave, Columbus, OH 43210, Tel: 614-292-0075, Email: Donneyong.1{at}osu.edu
Posted May 19, 2021.
A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model
